CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,174,464
+4.2%
793,557
+13.4%
0.00%
Q2 2023$1,127,056
-41.1%
700,035
+6.1%
0.00%
-100.0%
Q1 2023$1,914,215
-17.6%
660,074
-6.8%
0.00%0.0%
Q4 2022$2,322,122
-10.4%
707,964
+3.3%
0.00%0.0%
Q3 2022$2,592,000
-50.2%
685,519
+2.6%
0.00%
-50.0%
Q2 2022$5,205,000
-12.7%
668,042
+4.1%
0.00%0.0%
Q1 2022$5,964,000
-38.6%
641,875
+4.1%
0.00%
-33.3%
Q4 2021$9,716,000
-7.1%
616,461
+5.5%
0.00%0.0%
Q3 2021$10,464,000
+16.0%
584,529
+0.8%
0.00%0.0%
Q2 2021$9,021,000
+11.1%
580,100
+2.6%
0.00%0.0%
Q1 2021$8,119,000
-18.6%
565,376
+11.2%
0.00%
-25.0%
Q4 2020$9,980,000
+59.6%
508,365
+5.4%
0.00%
+33.3%
Q3 2020$6,252,000
+9.5%
482,336
+23.1%
0.00%0.0%
Q2 2020$5,709,000
+90.7%
391,828
+11.4%
0.00%
+50.0%
Q1 2020$2,993,000
-45.3%
351,670
+6.0%
0.00%
-33.3%
Q4 2019$5,467,000
+19.6%
331,911
+2.5%
0.00%0.0%
Q3 2019$4,572,000
-14.7%
323,730
+21.4%
0.00%0.0%
Q2 2019$5,362,000
-47.1%
266,632
+4.6%
0.00%
-50.0%
Q1 2019$10,132,000
+21.0%
254,868
+5.7%
0.01%0.0%
Q4 2018$8,375,000
-16.3%
241,057
-0.4%
0.01%
-14.3%
Q3 2018$10,010,000
+21.4%
242,062
+7.9%
0.01%
+16.7%
Q2 2018$8,245,000
+10.7%
224,352
+17.5%
0.01%0.0%
Q1 2018$7,445,000
+293.1%
190,880
+82.5%
0.01%
+200.0%
Q4 2017$1,894,000
+32.1%
104,612
+20.8%
0.00%
+100.0%
Q3 2017$1,434,000
+10.1%
86,617
-6.8%
0.00%0.0%
Q2 2017$1,302,000
-20.4%
92,974
+16.8%
0.00%
-50.0%
Q1 2017$1,636,000
+53.3%
79,580
+5.9%
0.00%
+100.0%
Q4 2016$1,067,000
-29.9%
75,134
+5.6%
0.00%
-50.0%
Q3 2016$1,522,000
+1.9%
71,130
+7.3%
0.00%0.0%
Q2 2016$1,493,000
+47.2%
66,295
+24.4%
0.00%
+100.0%
Q1 2016$1,014,000
-26.4%
53,275
+2.2%
0.00%
-50.0%
Q4 2015$1,377,000
-13.3%
52,121
+3.2%
0.00%0.0%
Q3 2015$1,589,000
-2.2%
50,513
+64.0%
0.00%0.0%
Q2 2015$1,625,000
+85.9%
30,796
+46.5%
0.00%
+100.0%
Q1 2015$874,000
+160.9%
21,015
+67.8%
0.00%0.0%
Q4 2014$335,00012,5230.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KPCB XV Associates, LLC 1,876,650$29,182,00013.03%
Copernicus Capital Management, LLC 50,000$778,00012.27%
Antipodean Advisors LLC 1,000,000$15,550,0004.28%
BRIDGER MANAGEMENT, LLC 1,325,188$20,607,0001.92%
Redmile Group, LLC 6,449,577$100,291,0001.48%
MAVERICK CAPITAL LTD 7,704,676$119,808,0001.12%
Baupost Group 8,477,488$131,825,0001.07%
ACT CAPITAL MANAGEMENT, LLC 116,900$1,818,0000.93%
Trellus Management Company, LLC 73,056$1,136,0000.78%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$8,164,0000.75%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders